Clinical Trials Indemnification Clauses: Pitfalls and Problems to Avoid is the management report that examines the most problematic areas in negotiating indemnification clauses. This report highlights the key topics you need to address and provides insight into the types of agreements that are generally accepted standards in the industry.

Designed to put at ease anyone who has ever worried about what should be covered by indemnification clauses in clinical trial agreements, this new report covers:

• Intentional misconduct
• Negligence
• Workplace injuries
• Insurance
• Limited liability clauses

Clinical Trials Indemnification Clauses: Pitfalls and Problems to Avoid will put to rest your lingering questions about what should and should not be contained in these troublesome clauses. Place your order today and get:

• Sample language to address some of the thorniest indemnification topics
• Real-world information about standard practices in indemnification clauses
• Insights for dealing with public entities, which may or may not be able to indemnify
• Practical advice for mediating some areas of frequent disagreement
• Guidance about which indemnification topics vary widely state by state

Clinical Trials Indemnification Clauses is a must for everyone involved in negotiating clinical trials contracts — sites, sponsors, CROs and law firms.

Buy Now!
Even when traditional indemnification won’t work, Clinical Trials Indemnification Clauses: Pitfalls and Problems to Avoid can help you find another way to cover risk. It’s just $327 and available to you today in PDF format.

Satisfaction Guaranteed
There's no risk when you purchase from FDAnews with our money-back guarantee. Not satisfied with your management report? Return the hard copy within 30 days (in resalable condition) and we will refund 100 percent of your purchase price (less shipping/handling). For the PDF format, you must notify FDAnews within 24 hours of receipt of purchase to receive a refund.